156 related articles for article (PubMed ID: 37195736)
1. Anti-tumour effect of Huangqin Decoction on colorectal cancer mice through microbial butyrate mediated PI3K/Akt pathway suppression.
Zhu JJ; Liu HY; Yang LJ; Fang Z; Fu R; Chen JB; Liu S; Fei BY
J Med Microbiol; 2023 May; 72(5):. PubMed ID: 37195736
[No Abstract] [Full Text] [Related]
2. Study on the mechanism of Huangqin Decoction on rats with ulcerative colitis of damp-heat type base on mtDNA, TLR4, p-PI3K, p-Akt protein expression and microbiota.
Zheng Y; Liang C; Li Z; Chen J; Chen Z; Jiang Y; Dong Q; Xiao Y; Fu C; Liao W; Yuan X
J Ethnopharmacol; 2022 Sep; 295():115356. PubMed ID: 35568112
[TBL] [Abstract][Full Text] [Related]
3. Huangqin Decoction ameliorates ulcerative colitis by regulating fatty acid metabolism to mediate macrophage polarization via activating FFAR4-AMPK-PPARα pathway.
Li MY; Wu YZ; Qiu JG; Lei JX; Li MX; Xu N; Liu YH; Jin Z; Su ZR; Lee SM; Zheng XB; Xiao-Qi H
J Ethnopharmacol; 2023 Jul; 311():116430. PubMed ID: 36997133
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice.
Chen G; Yang Y; Hu C; Cheng X; Xu Y; Cai X; Wang M; Yang CS; Cao P
Oncotarget; 2016 Sep; 7(38):61643-61655. PubMed ID: 27557503
[TBL] [Abstract][Full Text] [Related]
5. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier.
Li MX; Li MY; Lei JX; Wu YZ; Li ZH; Chen LM; Zhou CL; Su JY; Huang GX; Huang XQ; Zheng XB
Phytomedicine; 2022 Jun; 100():154052. PubMed ID: 35344714
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Effects of Huangqin Decoction on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice Through Regulation of the Gut Microbiota and Suppression of the Ras-PI3K-Akt-HIF-1α and NF-κB Pathways.
Li MY; Luo HJ; Wu X; Liu YH; Gan YX; Xu N; Zhang YM; Zhang SH; Zhou CL; Su ZR; Huang XQ; Zheng XB
Front Pharmacol; 2019; 10():1552. PubMed ID: 32038240
[TBL] [Abstract][Full Text] [Related]
7. Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway.
Wei J; Zheng Z; Hou X; Jia F; Yuan Y; Yuan F; He F; Hu L; Zhao L
J Ethnopharmacol; 2024 Jan; 318(Pt A):116866. PubMed ID: 37429503
[TBL] [Abstract][Full Text] [Related]
8. Huangqin Decoction Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via Inhibiting TNF-α-Induced NF-κB Activation.
Gu LM; Li H; Xia JQ; Pan CY; Gu C; Tian YZ
Chin J Integr Med; 2022 Feb; 28(2):124-129. PubMed ID: 34874516
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota drives the attenuation of dextran sulphate sodium-induced colitis by Huangqin decoction.
Yang Y; Chen G; Yang Q; Ye J; Cai X; Tsering P; Cheng X; Hu C; Zhang S; Cao P
Oncotarget; 2017 Jul; 8(30):48863-48874. PubMed ID: 28415628
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
11. Effect of Huangqin decoction on regulating intestinal flora in colitis mice characterized as inhibition of the NOD2-dependent pathway.
Huang S; He J; Chen Y; Wang X; Li Y; Su Y; Wen R; Li X; Yang G; Luo S; Zhou L; Luo X
Pharm Biol; 2022 Dec; 60(1):108-118. PubMed ID: 34967696
[TBL] [Abstract][Full Text] [Related]
12. Microbial metabolite sodium butyrate enhances the anti-tumor efficacy of 5-fluorouracil against colorectal cancer by modulating PINK1/Parkin signaling and intestinal flora.
Li Y; He P; Chen Y; Hu J; Deng B; Liu C; Yu B; Dong W
Sci Rep; 2024 Jun; 14(1):13063. PubMed ID: 38844824
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic landscape of sodium butyrate-induced growth inhibition of human colorectal cancer organoids.
Li F; Wu Y; Yan Y; Wu S; Zhu J; Zhang G; Zhang P; Yuan L; Zeng Y; Liu Z
Mol Omics; 2022 Sep; 18(8):754-764. PubMed ID: 35837877
[TBL] [Abstract][Full Text] [Related]
14. Huangqin Decoction Delays Progress of Colitis-Associated Carcinogenesis by Regulating Nrf2/HO-1 Antioxidant Signal Pathway in Mice.
Gu LM; Li HZ; Gao L; Li H; Wei LF; Pan CY; Wu KX; Tian YZ
Chin J Integr Med; 2024 Feb; 30(2):135-142. PubMed ID: 37434030
[TBL] [Abstract][Full Text] [Related]
15. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
16. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
17. Effects of Huangqin Decoction on ulcerative colitis by targeting estrogen receptor alpha and ameliorating endothelial dysfunction based on system pharmacology.
Li MY; Li MX; Xu N; Li ZH; Zhang YM; Gan YX; Luo HJ; Zhou CL; Liu YH; Su ZR; Huang XQ; Zheng XB
J Ethnopharmacol; 2021 May; 271():113886. PubMed ID: 33524513
[TBL] [Abstract][Full Text] [Related]
18. Prevention of ulcerative colitis by Huangqin decoction: reducing the intestinal epithelial cell apoptosis rate through the IFN-γ/JAK/ETS signalling pathway.
Mo X; Tang K; Deng L; Zhou X; Li X; Zhang Y; Wang J
Pharm Biol; 2022 Dec; 60(1):1116-1125. PubMed ID: 35654745
[TBL] [Abstract][Full Text] [Related]
19. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
20. Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
Lan W; Zhao J; Chen W; Shang H; Peng J; Lin J
Anticancer Agents Med Chem; 2021; 21(15):1987-1995. PubMed ID: 33438566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
